The GsD model will allow the simulation of glucagon-like signaling specifically in hepatocytes independently of other metabolic changes associated with type 2 diabetes, such as hepatic lipid accumulation or pleiotropic effects of glucagon receptor signaling on metabolism (64), including direct actions on extrahepatic tissues such as brain (65). The gene discussed is GCGR; the disease is type 2 diabetes mellitus.